Table 2_Clinicopathological features and survival outcomes of HPV-independent versus HPV-a

A systematic review and meta-analysis comparing HPV-independent and HPV-associated cervical adenocarcinoma. The dataset likely contains pooled hazard ratios and odds ratios for survival outcomes and clinical features from studies searched up to March 2026. It was authored by Dan Wu and published under a CC-BY-4.0 license on figshare.

Use Cases

• Compare overall survival (OS) outcomes between HPV-independent and HPV-associated adenocarcinoma based on the pooled HR of 3.37.
• Analyze risks of distant metastasis or recurrence based on the pooled OR of 2.76.
• Investigate the association between HPV status and lymphovascular invasion (LVSI/LVI) based on the pooled OR of 3.00.
• Assess progression-free survival (PFS) differences based on the pooled HR of 2.94.

Strengths

• Follows PRISMA 2020 guidelines for systematic review and meta-analysis methodology.
• Reports specific pooled effect sizes with 95% confidence intervals, such as an HR of 3.37 for overall survival.
• Includes multiple outcome measures: OS, PFS, DFS, distant metastasis, local recurrence, and LVSI/LVI.

Limitations

• Column-level documentation is absent; field semantics must be inferred after download.
• Row count is unknown, which may limit suitability assessment.
• The 53.4 KB file size suggests a very limited scope, likely containing summary statistics rather than patient-level data.

Provenance

Source

figshare

Collection Method

Systematic review and meta-analysis of studies from PubMed, Web of Science, Scopus, Embase, and Cochrane Library.

Time Range

Studies from database inception to 01 March 2026.

Freshness

Last updated 2026-05 08 05:54:01; freshness should be verified.

Geography

null